2021

Pdia4 regulates β-cell pathogenesis in diabetes: molecular mechanism and targeted therapy

Tien-Fen Kuo, Shuo-Wen Hsu, Shou-Hsien Huang, Cicero Lee-Tian Chang, Ching-Shan Feng, Ming-Guang Huang, Tzung-Yan Chen, Meng-Ting Yang, Si-Tse Jiang, Tuan-Nan Wen, Chun-Yen Yang, Chung-Yu Huang, Shu-Huei Kao, Keng-Chang Tsai, Greta Yang

2020

Development of the first-in-class diabetes drug, PS1

2018

R&D of a botanical drug for diabetes

2017

Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway

Tien-Fen Kuo, Tzung-Yan Chen, Si-Tse Jiang, Kai-Wei Chen, Yi-Ming Chiang, Yi-Jou Hsu, Yan-Jun Liu, Hui-Ming Chen, Kazunari K. Yokoyama, Keng-Chang Tsai, Hsu-Hua Yeh, Yet-Ran Chen, Meng-Ting Yang, Chun-Yen Yang

2015

Research and development of Bidens pilosa for coccidiosis control

Cicero L.T. Chang

2013

Terapeutic potential and mechanism of cytopiloyne

Cicero Lee-Tian Chang, Hsien-Yueh Liu, Tien-Fen Kuo, Yi-Jou Hsu, Ming-Yi Shen, Chien-Yuan Pan, and Wen-Chin Yang

2010

Myeloid-derived suppressor cells prevent type 1 diabetes in murine models

2006

Cytopiloyne for preventing type 1 diabetes

Chang, C.、Chang,S.、Lee, Y.、Chiang, Y.、Chuang, D.、